Testing the Effect of the InsuPad Device in Daily Life Conditions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.
Also called NCT01594801
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 145 participants
- Sponsor
- Insuline Medical Ltd.
- Registry
-
NCT01594801
-
- Other papers using this trial's data
- The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT01594801. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Testing the Effect of the InsuPad Device in Daily Life Conditions
- Condition
- Diabetics Mellitus Type 1
- Condition
- Diabetes Mellitus Type 2
- Intervention (Device)
- InsuPad
- Lead sponsor
- Insuline Medical Ltd.
Record details
- Record id
cardio:ct-nct01594801- Content hash
b62bfe26aae1b1beb83685f01c5a62542594e25eb6bfa6bc959a7caeb45f3b42